deltatrials
Unknown OBSERVATIONAL NCT01560663

Predictors of Response to Neoadjuvant Docetaxel-Carboplatin Chemotherapy for Patients With Stage II and III Triple Negative Breast Cancer

Sponsor: Centro Nacional de Investigaciones Oncologicas CARLOS III

Conditions Breast Cancer Breast Cancer Stage II-III
Interventions Docetaxel- Carboplatin
Updated 14 times since 2017 Last updated: Sep 28, 2023 Started: Jan 31, 2012 Primary completion: Dec 31, 2023 Completion: Dec 31, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Breast Cancer and Breast Cancer Stage II-III and is currently ongoing. Centro Nacional de Investigaciones Oncologicas CARLOS III leads this study, which shows 14 recorded versions since 2012 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Apr 2017 · 3 months · monthly snapshot~Apr 2017 – ~Apr 2018 · 12 months · monthly snapshot~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshot~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshot~Sep 2018 – ~Sep 2020 · 24 months · monthly snapshot~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Dec 2021 · 3 months · monthly snapshot~Dec 2021 – ~Sep 2023 · 21 months · monthly snapshot~Sep 2023 – ~Oct 2023 · 30 days · monthly snapshot~Oct 2023 – ~Jul 2024 · 9 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Oct 2025 · 13 months · monthly snapshot~Oct 2025 – present · 9 months · monthly snapshot

Change History

14 versions recorded

  1. Oct 2025 — Present [monthly]

    Unknown

    Status: Active Not Recruiting → Unknown

  2. Sep 2024 — Oct 2025 [monthly]

    Active Not Recruiting

  3. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting

  4. Oct 2023 — Jul 2024 [monthly]

    Active Not Recruiting

    Status: Unknown Status → Active Not Recruiting

  5. Sep 2023 — Oct 2023 [monthly]

    Unknown Status

    Status: Recruiting → Unknown Status

▶ Show 9 earlier versions

  1. Dec 2021 — Sep 2023 [monthly]

    Recruiting

  2. Sep 2021 — Dec 2021 [monthly]

    Recruiting

  3. Jan 2021 — Sep 2021 [monthly]

    Recruiting

  4. Sep 2020 — Jan 2021 [monthly]

    Recruiting

  5. Sep 2018 — Sep 2020 [monthly]

    Recruiting

  6. Jun 2018 — Sep 2018 [monthly]

    Recruiting

  7. Apr 2018 — Jun 2018 [monthly]

    Recruiting

    Phase: NA → None

  8. Apr 2017 — Apr 2018 [monthly]

    Recruiting NA

    Phase: PHASE2 → NA

  9. Jan 2017 — Apr 2017 [monthly]

    Recruiting PHASE2

    First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Centro Nacional de Investigaciones Oncologicas CARLOS III
  • Hospital San Carlos, Madrid
  • Hospital Universitario Ramon y Cajal
  • Miguel Martín Jiménez
  • UNC Lineberger Comprehensive Cancer Center
Data source: Hospital General Universitario Gregorio Marañon

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations